Evelo Biosciences Inc (EVLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 29,587 | 28,738 | 27,559 | 32,710 | 27,656 |
| Operating Income | -29,587 | -28,738 | -27,559 | -32,710 | -27,656 |
| Interest Expense | 1,020 | 1,027 | 1,010 | 1,023 | 814 |
| Other Income | 209 | 20 | 14 | 159 | -3,075 |
| Pre-tax Income | -30,398 | -29,745 | -28,555 | -33,574 | -31,545 |
| Income Tax | 163 | 116 | 97 | 156 | 53 |
| Net Income Continuous | -30,561 | -29,861 | -28,652 | -33,730 | -31,598 |
| Net Income | $-30,561 | $-29,861 | $-28,652 | $-33,730 | $-31,598 |
| EPS Basic Total Ops | -8.07 | -11.20 | -10.80 | -12.60 | -11.80 |
| EPS Basic Continuous Ops | -8.07 | -11.14 | -10.73 | -12.63 | -11.84 |
| EPS Diluted Total Ops | -8.07 | -11.20 | -10.80 | -12.60 | -11.80 |
| EPS Diluted Continuous Ops | -8.07 | -11.14 | -10.73 | -12.63 | -11.84 |
| EPS Diluted Before Non-Recurring Items | -8.00 | -11.20 | -10.80 | N/A | N/A |
| EBITDA(a) | $-29,054 | $-28,221 | $-27,021 | $-32,122 | $-27,102 |